Strategic Partnerships and Portfolio Optimization for Accessible Medicines

The marcus evans Strategic Partnerships and Portfolio Optimization for Accessible Medicines conference taking place in Morristown, NJ on September 13-14, 2023 will present the most recent and useful analysis of management tools, digital technologies, and innovative strategies to grow your company amidst an increasingly difficult regulatory environment and a shift towards targeted medicine that will disrupt the future of pharma. Join your peers from Pharma and Biotech companies and learn how to navigate high-risk ventures and alliances to accomplish the most ambitious of organizational goals.

Attending This Premier marcus evans Conference Will Enable You to:

• Build on business development strategies to adjust to price erosion, rising manufacturing cost and manage innovation growth.
• Evolve the business model to create portfolio margins that continually move, survive and become more profitable.
• Commercialize portfolios by coming into alignment with the right partnerships to share financial burden.
• Overcome sourcing complexity, cost and shortages to maximize profits.
• Nail down filing requirements for ANDAs and NDAs applications.
• Interpret legal pathways to growth for Biosimilars and biologics market penetration.

Best Practices and Case Studies from:

• Robert Shapiro, Global Director, Portfolio Management,  Apotex Inc.
• Dinakaran Balasubramanian, Director Marketing, Specialty Generics, Reddy's Laboratories
• Candis Edwards, Senior Vice President, Specialty Regulatory Affairs and Pharmacovigilance, Amneal Pharmaceuticals
• Saman Mazahreh, Global Head, R&D Project Management Office (PMO), Hikma Pharmaceuticals
• Sami Yusuf, Vice President, Corporate Development, Mayo Clinic
• Divya Verma, Vice President, Marketing & Portfolio, Accord Healthcare US

For more information please contact: Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit: https://bit.ly/3XgJ1fa